Clinical Trial Update: Comparing an Investigational Medication Versus an Approved Medication in Reducing Cholesterol Levels (0653-025) [Phase 3]

View source ↗

Summary

Phase 3 trial comparing an investigational cholesterol-lowering medication to an approved therapy in hypercholesterolemia; the study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypercholesterolemia

Drugs mentioned

• Approved comparator cholesterol-lowering medication
• Investigational cholesterol-lowering medication

Snippet

Sponsor: Organon and Co | Conditions: Hypercholesterolemia | Phase 3 | Status: COMPLETED